Johnson & Johnson (NYSE:JNJ)
$ 253.62 -0.79 (-0.31%) Market Cap: 611.20 Bil Enterprise Value: 639.48 Bil PE Ratio: 29.39 PB Ratio: 7.19 GF Score: 81/100

Johnson & Johnson Investor Conference Call Transcript

Aug 03, 2026 / 12:00PM GMT
Release Date Price: $254.41 (-0.76%)
Operator

Good morning and welcome to Johnson & Johnson's OTTAVA investor conference call. (Operator Instructions) This call is being recorded. If anyone has any objections, you may disconnect at this time. (Operator Instructions)

I would now like to turn the conference call over to Johnson & Johnson. You may begin.

Ryan Koors
Johnson & Johnson - Vice President - Investor Relations

Good morning and thank you for joining us. This is Ryan Koors, Vice President of Investor Relations for Johnson & Johnson. Welcome to our OTTAVA investor call following the recent FDA approval. Following prepared remarks, we will have time for open Q&A. We anticipate this webcast will last approximately 45 minutes. Please note that we will only be taking questions on OTTAVA during today's call.

Please be advised that this presentation contains forward-looking statements related to the OTTAVA robotic surgical system. The viewer is cautioned not to rely on these forward-looking statements, which are based on the current expectations of future events using

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot